Astria Therapeutics Inc. (ATXS)
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Personalis Announces New Data from a Landmark Neoadjuvant Lung Cancer Trial Showing Superiority of Ultra-Sensitive, Tumor-Informed MRD Testing
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities
Aligos Therapeutics Announces Six Preclinical Presentations at the 2025 International HBV Meeting
Longeveron - Longeveron® Announces Key Leadership Updates
Equillium - Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAB BIO to Deliver Five Presentations Related to SAB-142 at the 2025 Annual Meeting of the European Association for the Study of Diabetes